Thinking Beyond Traditional Cardiovascular Risk Factors-Reference-Cited by-同舟云学术

Thinking Beyond Traditional Cardiovascular Risk Factors

Published:2011-12-04 Issue:1 Volume:63 Page:9-11
ISSN:0003-3197
Container-title:Angiology
language:en
Short-container-title:Angiology

Author:

Katsiki Niki¹,Koumaras Charalambos²,Athyros Vasilios G.²,Karagiannis Asterios²

Affiliation:

1. Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free Hospital campus, University College London Medical School, University College London (UCL), London, UK

2. Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/0003319711406256

Reference39 articles.

1. Incremental Value of Arterial Stiffness Over Traditional Risk Factors in Predicting Subclinical Cardiovascular Remodeling in Patients With Moderate Chronic Renal Failure

2. Arterial stiffness and ventricular stiffness: a couple of diseases or a coupling disease? A review from the cardiologist's point of view

3. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations

4. Anti-Inflammatory Drugs and Statins for Arterial Stiffness Reduction

5. Assessment of Arterial Stiffness, A Translational Medicine Biomarker System for Evaluation of Vascular Risk

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of estimated pulse wave velocity and socioeconomic status on the risk of stroke in men: a prospective cohort study;Journal of Hypertension;2022-03-02

2. Editorial: Arterial Stiffness, Central Haemodynamics and Non-Alcoholic Fatty Liver Disease: Links with Cardiovascular Risk and Effects of Drug Treatment;Current Vascular Pharmacology;2018-05-17

3. Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension;Current Vascular Pharmacology;2018-05-17

4. Diabetes and lipid metabolism;Hormones;2018-03

5. Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i): Their Role in Cardiometabolic Risk Management;Current Pharmaceutical Design;2017-05-12